Skip to main content
Terug
Watch Compare

NextCure, Inc.

Datakwaliteit: 83%
NXTC
NASDAQ Manufacturing Chemicals
€ 11,64
▲ € 0,43 (3,84%)
Marktkapitalisatie: 40,86 M
Prijs
€ 11,48
Marktkapitalisatie
40,86 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -50,09 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-209,58%
Onder sectorgemiddelde (-54,47%)
ROIC-138,93%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio2,97
Interest CoverageN/A

Waardering

PE (TTM|NTM)
-0,73 | -1,84
Boven sectorgemiddelde (-1,49)
P/B Ratio1,73
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -0,7 -1,5
P/B 1,7 1,6
ROE % -209,6 -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,9
D/E — 0,3

Koersdoel Analisten

3 analisten
Buy
Huidig
€ 11,64
+51.8%
Koersdoel
€ 17,67
€ 15,00
€ 18,00
€ 20,00
Vooruitzicht
Forward K/W -1,84
Forward WPA -€ 6,31
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 6,31
-€ 9,15 – -€ 3,47
 0,0 2
FY2026 -€ 8,21
-€ 8,81 – -€ 7,68
 0,0 3

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 2,29 -€ 0,81 +64,6%
Q32025 -€ 3,98 -€ 3,22 +19,2%
Q22025 -€ 4,62 -€ 11,29 -144,6%
Q12025 -€ 4,80 -€ 4,68 +2,5%

ETFs Holding This Stock

DLHAX DLHAX
0,03% weight
DLRHX DLRHX
0,03% weight
DLHIX DLHIX
0,03% weight
BRSIX BRSIX
0,02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -55,84 M
ROE -209,58% ROA -127,93%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -50,09 M
ROIC -138,93% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,97
Interest Coverage N/A Asset Turnover N/A
Working Capital 21,65 M Tangible Book Value 23,65 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,73 Forward P/E -1,84
P/B Ratio 1,73 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -122,59%
Market Cap 40,86 M Enterprise Value 33,53 M
Per Share
EPS (Diluted TTM) -19,65 Revenue / Share N/A
FCF / Share -14,07 OCF / Share -13,93
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 89,69%
SBC-Adj. FCF -54,17 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 22,38 M
Net Income -55,84 M -55,65 M -62,72 M -74,73 M -69,39 M
EPS (Diluted) -19,65 -1,99 -2,25 -2,69 -2,51
Gross Profit — — — — —
Operating Income -57,62 M -59,75 M -67,64 M -75,91 M -70,77 M
EBITDA — — — — —
R&D Expenses 44,92 M 41,49 M 47,93 M 54,20 M 50,19 M
SG&A Expenses — — — — —
D&A 2,20 M 2,90 M 3,70 M 4,10 M 4,30 M
Interest Expense — — — — —
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 50,18 M 80,86 M 128,04 M 184,16 M 242,39 M
Total Liabilities 15,24 M 15,39 M 13,62 M 16,63 M 9,00 M
Shareholders' Equity 34,94 M 65,47 M 114,42 M 167,53 M 233,39 M
Total Debt — — — 0,0 0,0
Cash & Equivalents 25,98 M 27,73 M 13,08 M 26,63 M 12,34 M
Current Assets 43,75 M 71,81 M 112,73 M 163,98 M 227,82 M
Current Liabilities 10,57 M 9,57 M 6,88 M 9,13 M 6,61 M